Associated Papers
The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases.
Wysocka A et al.
International Journal of Molecular Sciences, 2021
PON1 promoter polymorphisms contribute to PCOS susceptibility and phenotypic outcomes in Indian women.
Dadachanji R et al.
Gene, 2018
Common genetic variants in the myeloperoxidase and paraoxonase genes and the related cancer risk: a review.
Yuzhalin AE et al.
Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews, 2012
Paraoxonase-1 (PON1) status in pancreatic cancer: relation to clinical parameters.
Vecka M et al.
Folia Biologica, 2012
The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome.
Lenarcik A et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology, 2010
Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration.
Pauer GJ et al.
American Journal of Ophthalmology, 2010
Genetic polymorphisms for the study of multifactorial stroke.
Bersano A et al.
Human Mutation, 2008
Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus.
Flekac M et al.
Physiological Research, 2008
Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia.
van Himbergen TM et al.
Journal of Lipid Research, 2005
Genetic determinants of arterial thrombosis.
Voetsch B et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
Genetic aspects of ischemic stroke: coagulation, homocysteine, and lipoprotein metabolism as potential risk factors.
Stankovic S et al.
Critical Reviews in Clinical Laboratory Sciences, 0
Select a paper to view details